Roughly speaking, we’re about halfway through what we can call Cannabis Earnings Season. This past week featured digits from prominent marijuana stocks including Cronos Group (NASDAQ:CRON) and GW Pharmaceuticals (NASDAQ:GWPH). And as we move through August, several more “green” equities will be reporting.
As usual with cannabis companies in this quickly developing sector, however, there was more going on than earnings updates. Here are some of the top happenings from a busy week.
Quarterly results: Cronos, CV Sciences, and GW Pharmaceuticals
Three noted marijuana stocks unveiled their latest quarterly figures last week — Cronos Group, hemp cannabidiol (CBD) products specialist CV Sciences (OTC:CVSI) and maker of cannabis-based medicine GW Pharmaceuticals.
Of the three, GW Pharmaceuticals had the best quarter by a wide margin. Thanks to the rapid uptake of its star drug, Epidiolex, its Q2 revenue ballooned more than twentyfold. Analysts